Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23240829 | 0.75 | CYP2C9 (0.41) | KMT2AMEN1MAPTCYP2C9HTT | |
| SCHEMBL17372112 | 0.73 | GRIN2D (0.42) | L3MBTL1SMN1; SMN2KMT2AMAPTCYP2C9 | |
| SCHEMBL11253970 | 0.71 | TDP1 (0.41) | L3MBTL1POLBSMN1; SMN2GLAKMT2A | |
| SCHEMBL643987 | 0.71 | PARP1 (0.39) | KMT2AMEN1MAPTCYP2C9HTT | |
| Hydrochloric Acid SCHEMBL11259779 | 0.70 | KDM4E (0.40) | L3MBTL1POLBSMN1; SMN2GLAKMT2A | |
| SCHEMBL103605 | 0.69 | GAA (0.44) | L3MBTL1POLBSMN1; SMN2GLAMAPT | |
| SCHEMBL8672229 | 0.68 | KMT2A (0.45) | KMT2AMEN1MAPTCYP2C9HTT | |
| SCHEMBL24063401 | 0.68 | TK1 (0.39) | PKMPMP22 | |
| SCHEMBL25424962 | 0.66 | KMT2A (0.42) | L3MBTL1SMN1; SMN2KMT2AMEN1MAPT | |
| Thymine SCHEMBL6686289 | 0.66 | ATAD2 (0.58) | L3MBTL1POLBSMN1; SMN2GLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119662655-A | Application of RNA molecule and composition thereof in tumor immunotherapy | 武汉厚先生物医药有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119522105-A | Signal sequences of nucleic acid vaccines | 赛诺菲 | 2025-02-25 | — | — | CN | disclosed |
| CN-118105474-A | Recombinant B-type meningococcal vaccine | 赛诺菲巴斯德有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117580568-A | Multivalent influenza vaccine | 赛诺菲 | 2024-02-20 | — | — | CN | disclosed |
| CN-117120082-A | Recombinant B-type meningococcal vaccine | 赛诺菲巴斯德有限公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023185072-A1 | ANTI-CD7 NANOBODY, AND DERIVATIVE THEREOF AND USE THEREOF IN TUMOR THERAPY | 河北森朗生物科技有限公司 | 2023-10-05 | — | — | WO | disclosed |
| CN-116406299-A | Lipid nanoparticles for delivery of mRNA vaccines | 赛诺菲 | 2023-07-07 | — | — | CN | disclosed |
| CN-115135765-A | Chemically modified oligonucleotides targeting bromodomain-containing protein 4(BRD4) for immunotherapy | 菲奥医药公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-114651070-A | Structure and temperature dependent flap endonuclease substrates | 精密科学公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-114344275-A | Encapsulation of messenger RNA | 川斯勒佰尔公司 | 2022-04-15 | — | — | CN | disclosed |
| US-20050148761-A1 | Genetic products of ashbya gossypii, associated with transmembrane transport | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-07 | — | — | US | disclosed |
| WO-2005049843-A2 | PLANT CELLS AND PLANTS WITH INCREASED RESISTANCE TO STRESS | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZÜRICH (CH) | 2005-06-02 | — | — | WO | disclosed |
| US-20050118583-A1 | Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | US | disclosed |
| US-20050069882-A1 | Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-31 | — | — | US | disclosed |
| US-20050053932-A1 | Novel stress-associated genetic products from ashbya gossypii | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-10 | — | — | US | disclosed |
| US-20040260058-A1 | Novel endothelially expressed dnas and proteins, and their use | AXARON BIOSCIENCE AG (DE) | 2004-12-23 | — | — | US | disclosed |
| WO-2004092349-A2 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
| US-20040111763-A1 | for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | disclosed |
| US-20040053379-A1 | Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs | BASF PLANT SCIENCE GMBH (DE) | 2004-03-18 | — | — | US | disclosed |
| US-20040049805-A1 | Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs | BASF PLANT SCIENCE GMBH (DE) | 2004-03-11 | — | — | US | disclosed |